Product Program year 2021 Source: CMS Open Payments

Follistim Aq

Biological Womens Health

NDC 0052-0326-01

Open in the dashboard

General payments

$70,865

2,597 payments

Research payments

$296,765

3 payments

Through program year 2021, $70,865 in general payments and $296,765 in research payments were reported against Follistim Aq (Womens Health).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Amount Payments
2021 General $7,497 376
2021 Research $45,795 1
2020 General $12,326 682
2020 Research $250,970 2
2019 General $51,043 1,539

Breakdown

Who paid General payments · program years 2019–2021
  1. Merck Sharp & Dohme Corporation $70,865 2,597 payments
Top recipients General payments · program year 2021
  1. John Zhang Reproductive Endocrinology · New York, NY $166 2% · 1 payment
  2. Akas Jain Reproductive Endocrinology · Westerville, OH $113 2% · 5 payments
  3. Priya Maseelall Reproductive Endocrinology · Akron, OH $89 1% · 4 payments
  4. Jane Nani Reproductive Endocrinology · Glenview, IL $88 1% · 4 payments
  5. Changnin Lee Brea, CA $79 1% · 4 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Reproductive Endocrinology Obstetrics & Gynecology $4,511 66% · 156 practitioners
  2. Obstetrics & Gynecology $801 12% · 28 practitioners
  3. Nurse Practitioner, Women's Health Nurse Practitioner $503 7% · 19 practitioners
  4. Nurse Practitioner, Family Nurse Practitioner $316 5% · 10 practitioners
  5. Physician Assistant $146 2% · 7 practitioners

The top 5 of 18 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $1,572 21% · 59 recipients
  2. New York $1,101 15% · 35 recipients
  3. Illinois $615 8% · 15 recipients
  4. Ohio $563 8% · 11 recipients
  5. Connecticut $511 7% · 17 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

2,597 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record